Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193321 | SCV000247573 | uncertain significance | not specified | 2015-03-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000193321 | SCV000313939 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000386251 | SCV000437672 | uncertain significance | Hermansky-Pudlak syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000193321 | SCV000701972 | benign | not specified | 2016-10-12 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000193321 | SCV000711325 | likely benign | not specified | 2016-06-07 | criteria provided, single submitter | clinical testing | p.Ile84Val in exon 4 of HPS4: This variant is not expected to have clinical sign ificance because it has been identified in 0.6% (400/66734) of European chromoso mes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; d bSNP rs149830675). |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625206 | SCV000744136 | likely benign | Hermansky-Pudlak syndrome 4 | 2017-06-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000970806 | SCV001118407 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Johns Hopkins Genomics, |
RCV000625206 | SCV001548509 | benign | Hermansky-Pudlak syndrome 4 | 2021-03-29 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000193321 | SCV001921618 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000970806 | SCV001930339 | likely benign | not provided | no assertion criteria provided | clinical testing |